Asbestos use and asbestos-related diseases in Asia

Past, present and future

Giang Vinh Le, Ken Takahashi, Eun Kee Park, Vanya Delgermaa, Chulho Oak, Ahmad Munir Qureshi, Syed Mohamed Al-Junid Syed Junid

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Background and objective: Although there are growing concerns about the global epidemic of asbestos-related diseases (ARD), the current status of asbestos use and ARD in Asia is elusive. We conducted a descriptive analysis of available data on asbestos use and ARD to characterize the current situation in Asia. Methods: We used descriptive indicators of per capita asbestos use (kilograms per capita per year) and age-adjusted mortality rates (AAMR, persons per million population per year) by country and for the region, with reference to the world. Results: The proportion of global asbestos use attributed to Asia has been steadily increasing over the years from 14% (1920-1970) to 33% (1971-2000) to 64% (2001-2007). This increase has been reflected in the absolute level of per capita use across a wide range of countries. In contrast, 12 882 ARD deaths have been recorded cumulatively in Asia, which is equivalent to only 13% of the cumulative number of ARD deaths in the world during the same period. The highest AAMR were recorded in Cyprus (4.8), Israel (3.7) and Japan (3.3), all of which have banned asbestos use. Conclusions: There is a paucity of information concerning the current situation of ARD in Asia. The marked increase in asbestos use in Asia since 1970, however, is likely to trigger a surge of ARD in the immediate decades ahead.

Original languageEnglish
Pages (from-to)767-775
Number of pages9
JournalRespirology
Volume16
Issue number5
DOIs
Publication statusPublished - Jul 2011
Externally publishedYes

Fingerprint

Asbestos
Cyprus
Israel
Japan

Keywords

  • Asbestos
  • Asbestosis
  • Asia
  • Mesothelioma
  • Mortality

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Asbestos use and asbestos-related diseases in Asia : Past, present and future. / Le, Giang Vinh; Takahashi, Ken; Park, Eun Kee; Delgermaa, Vanya; Oak, Chulho; Qureshi, Ahmad Munir; Syed Junid, Syed Mohamed Al-Junid.

In: Respirology, Vol. 16, No. 5, 07.2011, p. 767-775.

Research output: Contribution to journalArticle

Le, GV, Takahashi, K, Park, EK, Delgermaa, V, Oak, C, Qureshi, AM & Syed Junid, SMA-J 2011, 'Asbestos use and asbestos-related diseases in Asia: Past, present and future', Respirology, vol. 16, no. 5, pp. 767-775. https://doi.org/10.1111/j.1440-1843.2011.01975.x
Le GV, Takahashi K, Park EK, Delgermaa V, Oak C, Qureshi AM et al. Asbestos use and asbestos-related diseases in Asia: Past, present and future. Respirology. 2011 Jul;16(5):767-775. https://doi.org/10.1111/j.1440-1843.2011.01975.x
Le, Giang Vinh ; Takahashi, Ken ; Park, Eun Kee ; Delgermaa, Vanya ; Oak, Chulho ; Qureshi, Ahmad Munir ; Syed Junid, Syed Mohamed Al-Junid. / Asbestos use and asbestos-related diseases in Asia : Past, present and future. In: Respirology. 2011 ; Vol. 16, No. 5. pp. 767-775.
@article{09cf2726d2a74750bb88d9d086cb8e63,
title = "Asbestos use and asbestos-related diseases in Asia: Past, present and future",
abstract = "Background and objective: Although there are growing concerns about the global epidemic of asbestos-related diseases (ARD), the current status of asbestos use and ARD in Asia is elusive. We conducted a descriptive analysis of available data on asbestos use and ARD to characterize the current situation in Asia. Methods: We used descriptive indicators of per capita asbestos use (kilograms per capita per year) and age-adjusted mortality rates (AAMR, persons per million population per year) by country and for the region, with reference to the world. Results: The proportion of global asbestos use attributed to Asia has been steadily increasing over the years from 14{\%} (1920-1970) to 33{\%} (1971-2000) to 64{\%} (2001-2007). This increase has been reflected in the absolute level of per capita use across a wide range of countries. In contrast, 12 882 ARD deaths have been recorded cumulatively in Asia, which is equivalent to only 13{\%} of the cumulative number of ARD deaths in the world during the same period. The highest AAMR were recorded in Cyprus (4.8), Israel (3.7) and Japan (3.3), all of which have banned asbestos use. Conclusions: There is a paucity of information concerning the current situation of ARD in Asia. The marked increase in asbestos use in Asia since 1970, however, is likely to trigger a surge of ARD in the immediate decades ahead.",
keywords = "Asbestos, Asbestosis, Asia, Mesothelioma, Mortality",
author = "Le, {Giang Vinh} and Ken Takahashi and Park, {Eun Kee} and Vanya Delgermaa and Chulho Oak and Qureshi, {Ahmad Munir} and {Syed Junid}, {Syed Mohamed Al-Junid}",
year = "2011",
month = "7",
doi = "10.1111/j.1440-1843.2011.01975.x",
language = "English",
volume = "16",
pages = "767--775",
journal = "Respirology",
issn = "1323-7799",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Asbestos use and asbestos-related diseases in Asia

T2 - Past, present and future

AU - Le, Giang Vinh

AU - Takahashi, Ken

AU - Park, Eun Kee

AU - Delgermaa, Vanya

AU - Oak, Chulho

AU - Qureshi, Ahmad Munir

AU - Syed Junid, Syed Mohamed Al-Junid

PY - 2011/7

Y1 - 2011/7

N2 - Background and objective: Although there are growing concerns about the global epidemic of asbestos-related diseases (ARD), the current status of asbestos use and ARD in Asia is elusive. We conducted a descriptive analysis of available data on asbestos use and ARD to characterize the current situation in Asia. Methods: We used descriptive indicators of per capita asbestos use (kilograms per capita per year) and age-adjusted mortality rates (AAMR, persons per million population per year) by country and for the region, with reference to the world. Results: The proportion of global asbestos use attributed to Asia has been steadily increasing over the years from 14% (1920-1970) to 33% (1971-2000) to 64% (2001-2007). This increase has been reflected in the absolute level of per capita use across a wide range of countries. In contrast, 12 882 ARD deaths have been recorded cumulatively in Asia, which is equivalent to only 13% of the cumulative number of ARD deaths in the world during the same period. The highest AAMR were recorded in Cyprus (4.8), Israel (3.7) and Japan (3.3), all of which have banned asbestos use. Conclusions: There is a paucity of information concerning the current situation of ARD in Asia. The marked increase in asbestos use in Asia since 1970, however, is likely to trigger a surge of ARD in the immediate decades ahead.

AB - Background and objective: Although there are growing concerns about the global epidemic of asbestos-related diseases (ARD), the current status of asbestos use and ARD in Asia is elusive. We conducted a descriptive analysis of available data on asbestos use and ARD to characterize the current situation in Asia. Methods: We used descriptive indicators of per capita asbestos use (kilograms per capita per year) and age-adjusted mortality rates (AAMR, persons per million population per year) by country and for the region, with reference to the world. Results: The proportion of global asbestos use attributed to Asia has been steadily increasing over the years from 14% (1920-1970) to 33% (1971-2000) to 64% (2001-2007). This increase has been reflected in the absolute level of per capita use across a wide range of countries. In contrast, 12 882 ARD deaths have been recorded cumulatively in Asia, which is equivalent to only 13% of the cumulative number of ARD deaths in the world during the same period. The highest AAMR were recorded in Cyprus (4.8), Israel (3.7) and Japan (3.3), all of which have banned asbestos use. Conclusions: There is a paucity of information concerning the current situation of ARD in Asia. The marked increase in asbestos use in Asia since 1970, however, is likely to trigger a surge of ARD in the immediate decades ahead.

KW - Asbestos

KW - Asbestosis

KW - Asia

KW - Mesothelioma

KW - Mortality

UR - http://www.scopus.com/inward/record.url?scp=79959883967&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959883967&partnerID=8YFLogxK

U2 - 10.1111/j.1440-1843.2011.01975.x

DO - 10.1111/j.1440-1843.2011.01975.x

M3 - Article

VL - 16

SP - 767

EP - 775

JO - Respirology

JF - Respirology

SN - 1323-7799

IS - 5

ER -